PLAY PODCASTS
All About Merck's Molnupiravir Drug

All About Merck's Molnupiravir Drug

Morning Brief

October 11, 202112m 54s

Audio is streamed directly from the publisher (traffic.omny.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Last week, Health Minister Khairy Jamaludin said that the government would procure 150,000 treatment packages of a Covid-19 anti-viral drug produced by Merck called Molnupiravir. The drug is being described by many quarters as a gamechanger in the fight against Covid-19. Based on trials conducted so far, the medication was shown to reduce the risk of hospitalization or death by around 50% in patients with mild-to-moderate symptoms of the virus. We get the lowdown on Molnupiravir from Sam Fazeli, Director of Research at Bloomberg Intelligence.

Image credit: Quality Stock Arts / Shutterstock.com

See omnystudio.com/listener for privacy information.

Topics

Business AnalysisTrends and ForecastsMarketsPoliticsSocial IssuesHealth PolicyDiseases & ConditionsMental HealthHealthy LivingFitnessMedical Innovation and Technologylaw & legal mattersScienceInvestments